Search
SOLACI Congress
SOLACI CongressesSOLACI-SOCIME'18

SOLACI-SOCIME’18

solaci
solaci
61
0

Here you will find the most relevant articles about the SOLACI-SOCIME 2018 Congress, held on August 1st, 2nd & 3rd at Expo Santa Fe

If you cannot view the articles, click here.

Previous article
TAVR in Patients with Classical Low Flow, Low Gradient
Next article
Peri-Procedural Infarction: More Frequent than and Not as Innocent as We Thought
solaci
solaci

More articles by this author

SOLACI-SBHCI 23

solaci - 0
Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.

PCI-Advances in DIABETIC PATIENTS – MIL & WIN SESSION – SOLACI-SOCIME 2022

solaci - 0
✔️ PCI-Advances in DIABETIC PATIENTES - MIL & WIN SESSION ✔️ SOLACI-SOCIME 2022 Scientific Session 👨‍🏫 Contents: 00:10 - Welcoming words - Dra. Emma Miranda (MEX)...

SOLACI-SOCIME 22

solaci - 0
Here you will find the most relevant articles about the SOLACI-SOCIME 2022 Congress. If you cannot view the articles, click here.

SOLACI-CACI 21

solaci - 0
Here you will find the most relevant articles about the SOLACI-CACI 2021 Congress. If you cannot view the articles, click here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Congresses

SOLACI-SBHCI 23

Here you will find the most relevant articles about the SOLACI-SBHCI 2023 Congress. If you cannot view the articles, click here.
solaci -
SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

solaci - 0
Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Dr. Omar Tupayachi - 0
TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

Dr. Omar Tupayachi - 0
The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

solaci - 0
Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

Dr. Omar Tupayachi - 0
TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

Dr. Omar Tupayachi - 0
The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

Institutional News

Hemodynamics and Interventional Cardioangiology Hybrid Training Course SOLACI-CACI

solaci - 0
We are now open for registration to the hybrid training course on Hemodynamics and Interventional Cardioangiology for Technicians and Nurses SOLACI-CACI 2025 Find all course...

Check out the best images of the El Salvador 2024 Sessions

solaci - 0
Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

solaci - 0
The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy